REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
03/28/2026
Back to search
Official data from USPTO
INFLUENZA VACCINE FLUCELVAX QUADRIVALENT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
03/29/2026
Classification
Registered
Trademark type
Combined
Nice classes
5
Filing date
08/11/2016
Registration date
03/28/2017
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/28/2023
Last transaction
03/29/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
07/27/2016
First use in commerce
07/27/2016
Drawing code
3
Owner type
99
Owner location
Maidenhead, Berkshire, GB
Examiner
SMITH, CYNTHIA RINALDI
Law office
L70
Current location
TMEG LAW OFFICE 107
Mark description
The mark consists of the words "INFLUENZA VACCINE" above the term "FLUCELVAX". Under the term "FLUCELVAX" is the word "QUADRIVALENT". Around the letters "NE" in "VACCINE" is a semi-circular starburst design composed of dots of various sizes.
Holders and representatives
Holders
Seqirus UK Limited
Seqirus UK Limited
Representatives
Nancy Sabarra FROSS ZELNICK LEHRMAN & ZISSU, P.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Influenza vaccines for human use
Publications
History of USPTO decisions and trademark events.
23 publications found
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
07/28/2023
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
07/28/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/28/2023
E815
TEAS SECTION 8 & 15 RECEIVED
02/01/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/28/2022
CORV
REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
04/05/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
03/28/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/31/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/10/2017
PUBO
PUBLISHED FOR OPPOSITION
01/10/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/21/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
12/08/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/28/2016
DOCK
ASSIGNED TO EXAMINER
11/22/2016
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/29/2016
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/29/2016
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
08/31/2016
ALIE
ASSIGNED TO LIE
08/25/2016
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
08/18/2016
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
08/17/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/17/2016
NWAP
NEW APPLICATION ENTERED
08/15/2016
Continuous trademark protection
Get notified about every new filing that threatens INFLUENZA VACCINE FLUCELVAX QUADRIVALENT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.